Symantec Reiterated as Top Pick and 3 Stock Analyses to Note
Celgene Corporation (NASDAQ:CELG): Current Price: $96.50
The company’s price target has been raised by Cantor after Celgene raised its guidance last week. Additionally, the firm raised its target based on its optimism regarding the company’s ABRAXANE and apremilast drugs, and it keeps its Buy rating on the stock.
Abercrombie & Fitch Co. (NYSE:ANF): Current Price: $48.31
According to Janney Capital, Abercrombie will likely benefit from positive inventory and an inflection in GMROI, which caused improved margin performance. Shares have a Buy rating.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
Symantec Corporation (NASDAQ:SYMC): Current Price: $19.98
Citigroup has decided to keep Symantec as a top pick, and the firm expects the company’s January 23 event to focus on the turnaround story. There should be no surprises from the Q3 results, and the firm keeps its Buy rating on the stock with a $24 price target.
Team Health Holdings, Inc. (NYSE:TMH): Current Price: $31.88
The company’s price target has been raised by Stifel Nicolaus since the firm found a strong correlation between year-over-year changes in flu activity and Team’s same-store volumes. This has caused the firm to believe that the company could possibly report higher Q4 EPS than previously predicted, and it keeps its Buy rating on the stock.
Investing Insights: Can Activision Outperform a Chaotic Industry?